Latest filing published 07 Jun 2021 for ACCENDRA HEALTH INC/VA/, €213k.
Filing timeline
BuySaleInsider track record
Mark P. Zacur: trading record in brief
Mark P. Zacur, listed as senior executive, appears in our data through filings on Accendra Health Inc/VA/ shares, published by SEC (Form 4). The record holds 8 filings, for trades running from 11 May 2020 to 4 June 2021.
The open-market record consists of 3 sales worth €1.1M, with no purchase. The rest of the record consists of 5 share grants. Since January 2021: no purchases and 3 sales on the market.
The latest filing, published on 7 June 2021, reports a share grant of €213k in Accendra Health Inc/VA/. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark P. Zacur
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,108 shares@ US$42.37Common StockSEC:0000075252-21-000120:1
- 12,746 shares@ US$42.42Common StockSEC:0000075252-21-000120:2
- 10,392 shares@ US$42.2354.7% of flowCommon StockSEC:0000075252-21-000120:0
- 5,203 shares@ US$33.41Common StockSEC:0000075252-21-000101:1
- 11,210 shares@ US$32.4745.3% of flowCommon StockSEC:0000075252-21-000101:0
- 23,433 shares0Common StockSEC:0000075252-21-000051:0
- 4,808 shares@ US$7.64Common StockSEC:0000075252-20-000085:0
- 48,276 shares0Common StockSEC:0000075252-20-000071:0
8 of 8 declarations
